250 related articles for article (PubMed ID: 27259689)
1. Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.
Stivarou T; Stellas D; Vartzi G; Thomaidou D; Patsavoudi E
Cancer Biol Ther; 2016 Aug; 17(8):799-812. PubMed ID: 27259689
[TBL] [Abstract][Full Text] [Related]
2. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
3. [Influence factors on the formation of mammospheres from breast cancer stem cells].
Huang MZ; Zhang FC; Zhang YY
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
5. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
6. Secreted heat shock protein 90 promotes prostate cancer stem cell heterogeneity.
Nolan KD; Kaur J; Isaacs JS
Oncotarget; 2017 Mar; 8(12):19323-19341. PubMed ID: 28038472
[TBL] [Abstract][Full Text] [Related]
7. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
Peng L; Li FX; Shao WF; Xiong JB
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
[TBL] [Abstract][Full Text] [Related]
8. POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells.
Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
Int J Cancer; 2017 Jun; 140(11):2517-2525. PubMed ID: 28214331
[TBL] [Abstract][Full Text] [Related]
9. NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity.
Kim DW; Cho JY
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513573
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.
Pan M; Li M; You C; Zhao F; Guo M; Xu H; Li L; Wang L; Dou J
J Cell Physiol; 2020 Feb; 235(2):1405-1416. PubMed ID: 31347176
[TBL] [Abstract][Full Text] [Related]
11. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
12. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.
Kim SH; Sehrawat A; Singh SV
Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606
[TBL] [Abstract][Full Text] [Related]
13. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells.
Montales MT; Rahal OM; Kang J; Rogers TJ; Prior RL; Wu X; Simmen RC
Carcinogenesis; 2012 Mar; 33(3):652-60. PubMed ID: 22219179
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
Rappa G; Lorico A
Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
[TBL] [Abstract][Full Text] [Related]
15. HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells.
Gallardo-Pérez JC; Adán-Ladrón de Guevara A; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1679-1690. PubMed ID: 28648642
[TBL] [Abstract][Full Text] [Related]
16. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
Kim SH; Singh SV
Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
[No Abstract] [Full Text] [Related]
18. Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
Kundu N; Ma X; Kochel T; Goloubeva O; Staats P; Thompson K; Martin S; Reader J; Take Y; Collin P; Fulton A
Breast Cancer Res Treat; 2014 Jan; 143(1):19-31. PubMed ID: 24281828
[TBL] [Abstract][Full Text] [Related]
19. Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway.
McClements L; Yakkundi A; Papaspyropoulos A; Harrison H; Ablett MP; Jithesh PV; McKeen HD; Bennett R; Donley C; Kissenpfennig A; McIntosh S; McCarthy HO; O'Neill E; Clarke RB; Robson T
Clin Cancer Res; 2013 Jul; 19(14):3881-93. PubMed ID: 23741069
[TBL] [Abstract][Full Text] [Related]
20. Mahanine, A dietary phytochemical, represses mammary tumor burden in rat and inhibits subtype regardless breast cancer progression through suppressing self-renewal of breast cancer stem cells.
Das M; Kandimalla R; Gogoi B; Dutta KN; Choudhury P; Devi R; Dutta PP; Talukdar NC; Samanta SK
Pharmacol Res; 2019 Aug; 146():104330. PubMed ID: 31251988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
